Directs the commissioner of health to adopt regulations to include alpha-gal syndrome on the list of communicable diseases that shall be required to be reported to the health officer of the local health district where such disease occurs, or to the department of health.
S10336 would require the New York State Commissioner of Health to add alpha-gal syndrome to the list of diseases that must be reported under the state sanitary code. Alpha-gal syndrome is a tick-associated allergic condition that can cause delayed allergic reactions to mammalian meat and related products. By placing it on the reportable-disease list, the bill would create a formal public health reporting requirement for cases identified by health care providers or laboratories under the applicable regulations.
The bill is narrowly focused on administrative public health reporting rather than treatment, insurance coverage, or criminal penalties. It directs the Department of Health to update its regulations so alpha-gal syndrome is included in the communicable-disease reporting framework in 10 NYCRR 2.1, and it takes effect 30 days after becoming law, with immediate authorization for any needed regulatory changes. The practical effect would be to give state and local health officials better visibility into the occurrence and geographic spread of the condition.
The bill would amend the state’s public health reporting regime by requiring alpha-gal syndrome to be treated as a reportable communicable disease under the sanitary code. This would affect health care providers, laboratories, local health districts, and the Department of Health by adding a new condition to the list of diseases that must be reported to public health authorities. It would not itself create a new substantive health benefit or mandate treatment, but it would expand surveillance and data collection for a condition linked to tick exposure and allergic reactions.
No committee transcript or vote record was provided, so there is no documented debate or recorded support/opposition to assess. Based on the bill text alone, the measure appears to be a public health reporting bill with a limited, technical purpose, which typically suggests a neutral to favorable policy posture. The absence of voting history or discussion means the overall sentiment cannot be measured from legislative proceedings in the materials provided.
The main policy question is whether alpha-gal syndrome belongs on the reportable-disease list, since it is an allergic syndrome rather than a classic infectious disease. Supporters would likely emphasize improved surveillance, public health tracking, and awareness of a growing tick-related condition. Potential concerns could come from providers or public health administrators about added reporting burden, the classification of the syndrome as communicable, or whether reporting requirements are the best tool for addressing a food allergy condition.